Proton Pump
Proton Pump(质子泵)
Proton pump is a protein complex that transport the H+ ion across the membranes of lysosomes and vacuoles to generate an electrical and chemical gradient that provide energy for ATP synthesis from ADP.
Proton Pump 相关产品(55)
- GC33575Esomeprazole potassium salt ((S)-Omeprazole potassium)CAS: 161796-84-5
An H + /K + -ATPase inhibitor
- GC36806Omeprazole D3CAS: 922731-01-9纯度: >98.50%
An internal standard for the quantification of omeprazole
- GC47537Lansoprazole-d4CAS: 934294-22-1纯度: >99.00%
An internal standard for the quantification of lansoprazole
- GC605305-HydroxylansoprazoleCAS: 131926-98-2纯度: >99.50%
5-Hydroxylansoprazole(AG1908)是血浆中Lansoprazole的活性代谢产物。Lansoprazole由CYP2C19代谢形成5-Hydroxylansoprazole。Lansoprazole是一种胃质子泵(proton-pump)抑制剂,可有效研究各种消化系统疾病。
- GC60975Lansoprazole Sulfide D4CAS: 1216682-38-0
LansoprazoleSulfideD4是LansoprazoleSulfide的氘代物。LansoprazoleSulfide是质子泵抑制剂Lansoprazole的活性代谢产物。LansoprazoleSulfide是一种口服活性抗结核药,细胞内的IC50值为0.59µM,肉汤中的IC50值为0.46µM。
- GC61155Omeprazole sodiumCAS: 95510-70-6纯度: >98.00%
An irreversible inhibitor of the gastric proton pump
- GC61863VerucopeptinCAS: 138067-14-8纯度: >98.00%
Verucopeptin 是一种有效的 HIF-1 (IC50=0.22 µM) 抑制剂,可以降低 HIF-1 靶基因的表达和 HIF-1α 的蛋白水平。通过直接靶向 v-ATPase ATP6V1G 亚基 (但不靶向 ATP1V1B2 或 ATP6V1D),Verucopeptin 强烈抑制 v-ATPase 活性。Verucopeptin 对耐药性癌细胞表现出抗肿瘤活性,常用作癌症相关研究。
- GC62885Caloxin 2A1 TFA纯度: >99.50%
Caloxin 2A1 TFA 是一种细胞外质膜 Ca2+-ATPase (PMCA) 肽抑制剂。Caloxin 2A1 TFA 不影响基础 Mg2+-ATPase 或 Na+-K+-ATPase。
- GC63335Omeprazole-13CD3CAS: 1261395-28-1
Omeprazole-13CD3 (H 16868-13CD3) 是一种 13C 标记和氘代标记 Omeprazole。Omeprazole (H 16868) 是一种质子泵 (proton pump) 抑制剂 (PPI),有潜力用于胃肠道疾病的研究。Omeprazole 竞争性抑制 CYP2C19 活性,Ki 为 2 到 6 μM。Omeprazole 还抑制革兰氏阳性菌和革兰氏阴性菌生长。Omeprazole 是中性鞘磷脂酶 (N-SMase) 的抑制剂(外泌体抑制剂)。
- GC63472ZastaprazanCAS: 2133852-18-1纯度: >99.50%
Zastaprazan 是一种 proton pump 抑制剂 (WO2018008929)。Zastaprazan 可用于胃肠道炎症或胃酸相关疾病的研究。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC32924 | Linaprazan (AZD0865) | 248919-64-4 | >98.50% | |
An H + /K + -ATPase inhibitor | ||||
| GC33575 | Esomeprazole potassium salt ((S)-Omeprazole potassium) | 161796-84-5 | - | |
An H + /K + -ATPase inhibitor | ||||
| GC35982 | EN6 | 1808714-73-9 | >99.00% | |
An activator of autophagy | ||||
| GC36009 | Esomeprazole magnesium salt | 1198768-91-0 | - | |
An H + /K + -ATPase inhibitor | ||||
| GC36806 | Omeprazole D3 | 922731-01-9 | >98.50% | |
An internal standard for the quantification of omeprazole | ||||
| GC36847 | Pantoprazole sodium | 138786-67-1 | >99.50% | |
A proton pump inhibitor | ||||
| GC36848 | Pantoprazole sodium hydrate | 164579-32-2 | >98.00% | |
A proton pump inhibitor | ||||
| GC37756 | Tenatoprazole sodium | 335299-59-7 | - | |
A proton pump inhibitor | ||||
| GC37920 | Vonoprazan | 881681-00-1 | >99.50% | |
A selective and reversible proton pump inhibitor | ||||
| GC39429 | Rabeprazole Sulfide | 117977-21-6 | >98.00% | |
An active metabolite of rabeprazole | ||||
| GC39734 | Diphyllin | 22055-22-7 | >99.50% | |
A lignan with diverse biological activities | ||||
| GC47537 | Lansoprazole-d4 | 934294-22-1 | >99.00% | |
An internal standard for the quantification of lansoprazole | ||||
| GC60530 | 5-Hydroxylansoprazole | 131926-98-2 | >99.50% | |
5-Hydroxylansoprazole(AG1908)是血浆中Lansoprazole的活性代谢产物。Lansoprazole由CYP2C19代谢形成5-Hydroxylansoprazole。Lansoprazole是一种胃质子泵(proton-pump)抑制剂,可有效研究各种消化系统疾病。 | ||||
| GC60929 | Ilaprazole sodium | 172152-50-0 | >98.50% | |
A gastric proton pump inhibitor | ||||
| GC60975 | Lansoprazole Sulfide D4 | 1216682-38-0 | - | |
LansoprazoleSulfideD4是LansoprazoleSulfide的氘代物。LansoprazoleSulfide是质子泵抑制剂Lansoprazole的活性代谢产物。LansoprazoleSulfide是一种口服活性抗结核药,细胞内的IC50值为0.59µM,肉汤中的IC50值为0.46µM。 | ||||
| GC61155 | Omeprazole sodium | 95510-70-6 | >98.00% | |
An irreversible inhibitor of the gastric proton pump | ||||
| GC61863 | Verucopeptin | 138067-14-8 | >98.00% | |
Verucopeptin 是一种有效的 HIF-1 (IC50=0.22 µM) 抑制剂,可以降低 HIF-1 靶基因的表达和 HIF-1α 的蛋白水平。通过直接靶向 v-ATPase ATP6V1G 亚基 (但不靶向 ATP1V1B2 或 ATP6V1D),Verucopeptin 强烈抑制 v-ATPase 活性。Verucopeptin 对耐药性癌细胞表现出抗肿瘤活性,常用作癌症相关研究。 | ||||
| GC62823 | Abeprazan | 1902954-60-2 | >99.50% | |
Abeprazan (DWP14012) 是一种钾竞争性酸 (potassium-competitive acid) 阻滞剂。Abeprazan 通过可逆的钾竞争性离子结合抑制 H+,K+- ATPase,而无需酸激活。Abeprazan 是一种潜在的质子泵抑制剂,用于研究与酸相关的疾病。 | ||||
| GC62885 | Caloxin 2A1 TFA | - | >99.50% | |
Caloxin 2A1 TFA 是一种细胞外质膜 Ca2+-ATPase (PMCA) 肽抑制剂。Caloxin 2A1 TFA 不影响基础 Mg2+-ATPase 或 Na+-K+-ATPase。 | ||||
| GC63335 | Omeprazole-13CD3 | 1261395-28-1 | - | |
Omeprazole-13CD3 (H 16868-13CD3) 是一种 13C 标记和氘代标记 Omeprazole。Omeprazole (H 16868) 是一种质子泵 (proton pump) 抑制剂 (PPI),有潜力用于胃肠道疾病的研究。Omeprazole 竞争性抑制 CYP2C19 活性,Ki 为 2 到 6 μM。Omeprazole 还抑制革兰氏阳性菌和革兰氏阴性菌生长。Omeprazole 是中性鞘磷脂酶 (N-SMase) 的抑制剂(外泌体抑制剂)。 | ||||
| GC63472 | Zastaprazan | 2133852-18-1 | >99.50% | |
Zastaprazan 是一种 proton pump 抑制剂 (WO2018008929)。Zastaprazan 可用于胃肠道炎症或胃酸相关疾病的研究。 | ||||
| GC63687 | Rabeprazole-d4 | 934295-48-4 | - | |
An internal standard for the quantification of rabeprazole | ||||
| GC63954 | KM91104 | 304481-60-5 | >99.00% | |
KM 91104 is a cell-permeable inhibitor of V-ATPase that specifically targets the interaction between V-ATPase subunit a3 and subunit B2. | ||||
| GC64070 | Omeprazole-d3-1 | 934293-92-2 | - | |
An internal standard for the quantification of omeprazole | ||||
